Raptor Pharmaceutical Corp. to Present at Two Upcoming Investor Conferences

Raptor Pharmaceutical Corp.
Press release

Raptor Pharmaceutical Corp. to Present at Two Upcoming Investor Conferences

NOVATO, Calif., 2012-08-07 12:30 CEST (GLOBE NEWSWIRE) -- Raptor Pharmaceutical
Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that Ted
Daley, President of Raptor, will present an overview of the Company at two
investor conferences in August. 

The conference presentation schedule is as follows:

Canaccord Genuity Annual Growth Conference                
August 14, 2012 at 10:00am ET                             
InterContinental, Boston, MA                              
                                                          
Wedbush PACGROW LIFE SCIENCES Management Access Conference
August 15, 2012 at 1:55pm ET                              
Le Parker Meridien, New York, NY                          

A live audio webcast and 14-day archive of the Canaccord and Wedbush
presentations will be available at http://ir.raptorpharma.com/events.cfm 

About Raptor Pharmaceutical Corp.

Raptor Pharmaceutical Corp. (Nasdaq:RPTP) ("Raptor") seeks to research,
produce, and deliver medicines that improve life for patients with severe, rare
disorders. Raptor currently has product candidates in clinical development to
potentially treat nephropathic cystinosis, Non-alcoholic Steatohepatitis
("NASH"), Huntington's Disease ("HD"), aldehyde dehydrogenase deficiency
("ALDH2"), and thrombotic disorder. 

Raptor's preclinical programs are based upon bioengineered novel drug
candidates and drug-targeting platforms derived from the human
receptor-associated protein and related proteins that are designed to target
cancer and infectious diseases. 

For additional information, please visit www.raptorpharma.com.

The Raptor Pharmaceutical Corp. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=7180 


         CONTACT: Trout Group (investors)
         Lauren Glaser
         (646) 378-2972
          
         
         
         EVC Group (media)
         Janine McCargo
         (646) 688-0425
          
Social Media Pitch:
Raptor Pharmaceutical Corp. to Present at Two Upcoming Investor Conferences